Atlas Trials

Study Will Assess Skin Irritation and Sensitization for HP-1050 Patch

Clinical trial NCT04624867 · UNKNOWN

Trial details

NCT number
NCT04624867
Sponsor
Noven Pharmaceuticals, Inc.
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cumulative Irritation and Sensitization
Start date
2020-11-03
Primary completion
2022-01-31
Enrollment
240

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.